TLR activation pathways in HIV-1-exposed seronegative individuals

Journal of Immunology

Volumn 184, Issue 5, 2010, Pages 2710-2717

  Biasin, Mara ^a   Piacentini, Luca ^a   Lo Caputo, Sergio ^c   Naddeo, Valentina ^a   Pierotti, Piera ^c   Borelli, Manuela ^a   Trabattoni, Daria ^a   Mazzotta, Francesco ^c   Shearer, Gene M ^d   Clerici, Mario ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^c SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; BETA INTERFERON; CD14 ANTIGEN; CD4 ANTIGEN; CUTANEOUS T CELL ATTRACTING CHEMOKINE; CYCLOOXYGENASE 2; IMIQUIMOD; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MYELOID DIFFERENTIATION FACTOR 88; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA; AMINOQUINOLINE DERIVATIVE; CCL3 PROTEIN, HUMAN; CYTOKINE; MESSENGER RNA; TLR3 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TLR7 PROTEIN, HUMAN; TLR8 PROTEIN, HUMAN;

ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; GENE TARGETING; HETEROSEXUALITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOSTIMULATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERODIAGNOSIS; SIGNAL TRANSDUCTION; ADAPTIVE IMMUNITY; BLOOD; CELL CULTURE; CYTOLOGY; FLOW CYTOMETRY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY;

ADAPTIVE IMMUNITY; AMINOQUINOLINES; CELLS, CULTURED; CHEMOKINE CCL3; CYTOKINES; FLOW CYTOMETRY; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; POLY I-C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 8; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77951930122     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902463     Document Type: Article

References (36)

1. Ranki, A., S. Mattinen, R. Yarchoan, S. Broder, J. Ghrayeb, J. Lähdevirta, and K. Krohn. 1989. T-cell response towards HIV in infected individuals with and without zidovudine therapy, and in HIV-exposed sexual partners. AIDS 3: 63-69. (Pubitemid 19073453)
2. Clerici, M., J. A. Berzofsky, G. M. Shearer, and C. O. Tacket. 1991. Exposure to human immunodeficiency virus (HIV) type I indicated by HIV-specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies [corrected]. J. Infect. Dis. 164: 178-182.
3. Liu, R., W. A. Paxton, S. Choe, D. Ceradini, S. R. Martin, R. Horuk, M. E. MacDonald, H. Stuhlmann, R. A. Koup, and N. R. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86: 367-377. (Pubitemid 26272077)
4. Piacentini, L., M. Biasin, C. Fenizia, and M. Clerici. 2009. Genetic correlates of protection against HIV infection: the ally within. J. Intern. Med. 265: 110-124.
5. Scott-Algara, D., L. X. Truong, P. Versmisse, A. David, T. T. Luong, N. V. Nguyen, I. Theodorou, F. Barré-Sinoussi, and G. Pancino. 2003. Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J. Immunol. 171: 5663-5667. (Pubitemid 37467178)
6. Shearer, G. M., and M. Clerici. 1996. Protective immunity against HIV infection: has nature done the experiment for us? Immunol. Today 17: 21-24.
7. Alimonti, J. B., J. Kimani, L. Matu, C. Wachihi, R. Kaul, F. A. Plummer, and K. R. Fowke. 2006. Characterization of CD8 T-cell responses in HIV-1-exposed seronegative commercial sex workers from Nairobi, Kenya. Immunol. Cell Biol. 84: 482-485.
8. Devito, C., K. Broliden, R. Kaul, L. Svensson, K. Johansen, P. Kiama, J. Kimani, L. Lopalco, S. Piconi, J. J. Bwayo, et al. 2000. Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J. Immunol. 165: 5170-5176.
9. Takeda, K., and S. Akira. 2007. Toll-like receptors. Curr. Protoc. Immunol. Chapter 14: Unit 14.12.
10. Barton, G. M. 2007. Viral recognition by Toll-like receptors. Semin. Immunol. 19: 33-40.
11. Heil, F., H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning, S. Akira, G. Lipford, H. Wagner, and S. Bauer. 2004. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303: 1526-1529. (Pubitemid 38314424)
12. Diebold, S. S., T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531.
13. Montoya, C. J., P. A. Velilla, C. Chougnet, A. L. Landay, and M. T. Rugeles. 2006. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals. Clin. Immunol. 120: 138-146.
14. Kebba, A., J. Stebbing, S. Rowland, R. Ingram, J. Agaba, S. Patterson, P. Kaleebu, N. Imami, and F. Gotch. 2005. Expression of the common heat-shock protein receptor CD91 is increased on monocytes of exposed yet HIV-1-seronegative subjects. J. Leukoc. Biol. 78: 37-42.
15. Biasin, M., L. Piacentini, S. Lo Caputo, Y. Kanari, G. Magri, D. Trabattoni, V. Naddeo, L. Lopalco, A. Clivio, E. Cesana, et al. 2007. Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals. J. Infect. Dis. 195: 960-964.
16. Burns, K., S. Janssens, B. Brissoni, N. Olivos, R. Beyaert, and J. Tschopp. 2003. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197: 263-268.
17. Biasin, M., S. L. Caputo, L. Speciale, F. Colombo, L. Racioppi, A. Zagliani, C. Blé, F. Vichi, L. Cianferoni, A. M. Masci, et al. 2000. Mucosal and systemic immune activation is present in human immunodeficiency virus-exposed seronegative women. J. Infect. Dis. 182: 1365-1374.
18. Jennes, W., S. Sawadogo, S. Koblavi-Dème, B. Vuylsteke, C. Maurice, T. H. Roels, T. Chorba, J. N. Nkengasong, and L. Kestens. 2003. Cellular human immunodeficiency virus (HIV)-protective factors: a comparison of HIV-exposed seronegative female sex workers and female blood donors in Abidjan, Côte d'Ivoire. J. Infect. Dis. 187: 206-214.
19. Tran, H. K., L. Chartier, L. X. Troung, N. N. Nguyen, A. Fontanet, F. E. Barré-Sinoussi, G. Pancino, and D. Scott-Algara. 2006. Systemic immune activation in HIV-1-exposed uninfected Vietnamese intravascular drug users. AIDS Res. Hum. Retroviruses 22: 255-261.
20. Thivierge, M., C. LeGouill, M. J. Tremblay, J. Stanková, and M. Rola-Pleszczynski. 1998. Prostaglandin E2 induces resistance to human immunodeficiency virus-1 infection in monocyte-derived macrophages: downregulation of CCR5 expression by cyclic adenosine monophosphate. Blood 92: 40-45.
21. Flamand, L., P. Borgeat, R. Lalonde, and J. Gosselin. 2004. Release of anti-HIV mediators after administration of leukotriene B4 to humans. J. Infect. Dis. 189: 2001-2009.
22. Sanghavi, S. K., and T. A. Reinhart. 2005. Increased expression of TLR3 in lymph nodes during simian immunodeficiency virus infection: implications for inflammation and immunodeficiency. J. Immunol. 175: 5314-5323.
23. Longhi, M. P., C. Trumpfheller, J. Idoyaga, M. Caskey, I. Matos, C. Kluger, A. M. Salazar, M. Colonna, and R. M. Steinman. 2009. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J. Exp. Med. 206: 1589-1602.
24. Alter, G., T. J. Suscovich, N. Teigen, A. Meier, H. Streeck, C. Brander, and M. Altfeld. 2007. Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells. J. Immunol. 178: 7658-7666. (Pubitemid 46898036)
25. Browne, E. P., and D. R. Littman. 2009. Myd88 is required for an antibody response to retroviral infection. PLoS Pathog. 5: e1000298.
26. Tudor, D., M. Derrien, L. Diomede, A. S. Drillet, M. Houimel, C. Moog, J. M. Reynes, L. Lopalco, and M. Bomsel. 2009. HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis. Mucosal Immunol. 2: 412-426.
27. Miyazawa, M., L. Lopalco, F. Mazzotta, S. Lo Caputo, F. Veas, M. Clerici, and ESN Study Group. 2009. The 'immunologic advantage' of HIV-exposed seronegative individuals. AIDS 23: 161-175.
28. Schlaepfer, E., A. Audigé, H. Joller, and R. F. Speck. 2006. TLR7/8 triggering exerts opposing effects in acute versus latent HIV infection. J. Immunol. 176: 2888-2895.
29. Meier, A., G. Alter, N. Frahm, H. Sidhu, B. Li, A. Bagchi, N. Teigen, H. Streeck, H. J. Stellbrink, J. Hellman, et al. 2007. MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J. Virol. 81: 8180-8191. (Pubitemid 47101504)
30. Beignon, A. S., K. McKenna, M. Skoberne, O. Manches, I. DaSilva, D. G. Kavanagh, M. Larsson, R. J. Gorelick, J. D. Lifson, and N. Bhardwaj. 2005. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J. Clin. Invest. 115: 3265-3275.
31. Schlaepfer, E., and R.F. Speck. 2008. Anti-HIV activity mediated by natural killer and CD8+ cells after toll-like receptor 7/8 triggering. PLoS One. 3: e1999.
32. Herbeuval, J. P., and G. M. Shearer. 2007. HIV-1 immunopathogenesis: how good interferon turns bad. Clin. Immunol. 123: 121-128.
33. Boasso, A., and G. M. Shearer. 2008. Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin. Immunol. 126: 235-242.
34. Fowke, K. R., N. J. Nagelkerke, J. Kimani, J. N. Simonsen, A. O. Anzala, J. J. Bwayo, K. S. MacDonald, E. N. Ngugi, and F. A. Plummer. 1996. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 348: 1347-1351.
35. Herbeuval, J. P., J. Nilsson, A. Boasso, A. W. Hardy, M. J. Kruhlak, S. A. Anderson, M. J. Dolan, M. Dy, J. Andersson, and G. M. Shearer. 2006. Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients. Proc. Natl. Acad. Sci. USA 103: 7000-7005.
36. Boasso, A., A. W. Hardy, S. A. Anderson, M. J. Dolan, and G. M. Shearer. 2008. HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation. PLoS One 3: e2961.